Search
for
Sort by
Research 841–870 of 1000+
- Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism
- A randomized blinded retrospective study: the combined use of micro-needling technique, low-level laser therapy and autologous non-activated platelet-rich plasma improves hair re-growth in patients with androgenic alopecia
- Exosome Therapy from Hypoxia-treated Mesenchymal Stem Cells Reduces TNF-α and Increases VEGF Levels in Fluconazole-Induced Alopecia Model
- Integrating Psychodermatology and Platelet-Rich Plasma Therapy in Various Dermatological Conditions: A Narrative Review
- Effects of Post-Therapy Changes on the Level of Immunoglobulin M in Dogs with Dermatitis
- Dermatologic Reactions to Targeted Therapy
- Pigmented contact dermatitis due to therapeutic sensitizer as complication of contact immunotherapy in alopecia areata
- Telogen Effluvium Associated with Albendazole Therapy
- Therapeutic potential and pharmacological insights of total glucosides of paeony in dermatologic diseases: a comprehensive review
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- Therapeutic Efficacy and Safety of Platelet-Rich Plasma (PRP) for Hair Restoration: A Narrative Review
- Hidradenitis suppurativa: a new therapeutic approach for an old disease
- Frontal fibrosing alopecia: treatment with oral dutasteride and topical pimecrolimus
- Advances In Mesenchymal Cell Therapy In Dermatology And Aesthetic Medicine
- Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil®, Finasteride®, and Adult Stem Cell-Based Therapy
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Increased Incidence of Telogen Effluvium Following Platelet-Rich Plasma Therapy in Patients with Elevated TNF-α Expression: A Prospective Cohort Study
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Finasteride and androgenic alopecia; from therapeutic options to medical implications
- Creatine phosphokinase levels and isotretinoin therapy
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Retinoids in scarless skin regeneration: from molecular mechanisms to therapeutic strategies
- Cirmcumscribed juvenile pityriasis rubra pilaris in a 5-year-old-girl treated with topical keratolytic and steroid
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection
- Cedrol mitigates hepatic lipid accumulation and adipocyte hypertrophy induced by corticosteroids through the inhibition of glucocorticoid receptor activity
- Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia
- Combined Ultrasound and Microneedle for Enhanced Transdermal Delivery: Synergistic Mechanisms and Therapeutic Advances